Novo Nordisk said that if approved for use, insulin icodec would reduce the number of basal insulin injections needed per year for type 2 diabetics from 365 to 52, a significant reduction in ...
Insulin icodec is an insulin analogue that binds strongly to albumin ... It would allow patients with insulin-dependent diabetes to cover their basal insulin needs with one injection per week ...
Novo Nordisk's 2024 earnings exceeded estimates, with strong performance in diabetes, obesity, and rare disease segments.
On days 2–5, pancreatic endocrine clamps were performed using somatostatin infusions of somatostatin and/or selective replacement of insulin and glucagon; day 2, GLP-1 plus basal insulin and ...
Adults with insulin-treated type 2 diabetes had a significant HbA1c decline at 13 weeks with use of the Omnipod 5 automated ...
Merilog is the third insulin biosimilar product approved by the FDA and joins the two long-acting insulin biosimilar products ...
The U.S. Food and Drug Administration approved Merilog as biosimilar to Novolog for the improvement of glycemic control in adults and pediatric ...
People with type 1 diabetes require continuous insulin treatment and must regularly measure their glucose levels. With open-loop therapies, insulin administration is manually controlled, while hybrid ...
Biological testing identified a psychoplastogenic iboga analogue that is a potent modulator of the serotonin transporter. CAR and PXR receptors are known to regulate metabolism, however ...
One of the most important inventions of the twentieth century was broadcasting with analogue radio and television systems. The last few years, however, have seen the birth of digital broadcasting.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback